Invasive pneumococcal diseases in Chinese children: a multicentre hospital-based active surveillance from 2019 to 2021

References

• O’Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902. doi:10.1016/S0140-6736(09)61204-6
   PubMed Web of Science ®Google Scholar
• Kan QC, Wen JG, Liu XH, et al. Inappropriate use of antibiotics in children in China. Lancet. 2016;387:1273–1274. doi:10.1016/S0140-6736(16)30019-8
   PubMed Web of Science ®Google Scholar
• Yao KH, Wang LB, Zhao GM, et al. Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia. Vaccine. 2011;29:2296–2301. doi:10.1016/j.vaccine.2011.01.027
   PubMed Web of Science ®Google Scholar
• Liang Q, Li GF, Zhu FC. Vaccine profile of PPV23: Beijing Minhai Biotech 23-valent pneumococcal vaccine. Expert Rev Vaccines. 2016;15:1351–1359. doi:10.1080/14760584.2016.1239536
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang J, Shao XJ, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study. Vaccine. 2021;39:4620–4627. doi:10.1016/j.vaccine.2021.06.075
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang Q, Yao KH, et al. Clinical characteristics and serotype distribution of invasive pneumococcal disease in pediatric patients from Beijing, China. Eur J Clin Microbiol Infect Dis. 2021;40:1833–1842. doi:10.1007/s10096-021-04238-x
   PubMed Web of Science ®Google Scholar
• Lai XZ, Brian W, Yu WZ, et al. National, regional, and provincial disease burden attributed to Streptococcus pneumoniae and Haemophilus influenzae type b in children in China: modelled estimates for 2010−17. Lancet Reg Health West Pac. 2022;22:100430. doi:10.1016/j.lanwpc.2022.100430
   PubMedGoogle Scholar
• Hausdorff WP, Bryant J, Paradiso PR, et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000;30:100–121. doi:10.1086/313608
   PubMed Web of Science ®Google Scholar
• Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect. 2005;5:83–93. doi:10.1016/S1473-3099(05)01280-6
   PubMed Web of Science ®Google Scholar
• Hausdorff WP, Siber G, Paradiso PR. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet. 2001;357:950–952. doi:10.1016/S0140-6736(00)04222-7
   PubMed Web of Science ®Google Scholar
• Waight PA, Andrews NJ, Ladhani NJ, et al. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015;15:535–543. doi:10.1016/S1473-3099(15)70044-7
   PubMed Web of Science ®Google Scholar
• Camilli R, DAmbrosio F, Grosso D, et al. Pneumococcal Surveillance Group. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure. Vaccine. 2017;35:4587–4593. doi:10.1016/j.vaccine.2017.07.010
   PubMed Web of Science ®Google Scholar
• Moore MR, Link-Gelles R, Schaffner W, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study. Lancet Respir Med. 2016;4:399–406. doi:10.1016/S2213-2600(16)00052-7
   PubMed Web of Science ®Google Scholar
• Zhu L, Li WH, Wang XH, et al. A multicenter clinical study on 1 138 cases of invasive pneumococcal disease in children from 2012 to 2017. Chin J Pediatr. 2018;56:915–922. doi:10.3760/cma.j.issn.0578-1310.2018.12.006
   Google Scholar
• Xue L, Yao KH, Xie GL, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates that cause invasive disease among Chinese children. Clin Infect Dis. 2010;50:741–744. doi:10.1086/650534
   PubMed Web of Science ®Google Scholar
• Zhou ML, Wang ZR, Zhang L, et al. Serotype distribution, antimicrobial susceptibility, multilocus sequencing type and virulence of invasive Streptococcus pneumoniae in China: A Six-year multicenter study. Front Microbiol. 2021;12:798750. doi:10.3389/fmicb.2021.798750
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2014). Revised WHO classification and treatment of childhood pneumonia at health facilities, evidence summaries.
   Google Scholar
• Sørensen UB. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol. 1993;31:2097–2100. doi:10.1128/jcm.31.8.2097-2100.1993
   PubMed Web of Science ®Google Scholar
• Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology. 1998;144:3049–3060. doi:10.1099/00221287-144-11-3049
   PubMed Web of Science ®Google Scholar
• Feil EJ, Li BC, Aanensen DM, et al. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol. 2004;186:1518–1530. doi:10.1128/JB.186.5.1518-1530.2004
   PubMed Web of Science ®Google Scholar
• Ptel JB, Patel R, Weinstein MP, et al. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. In: Twenty-seventh informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2017. p. M100-S27.
   Google Scholar
• Brueggemann AB, Rensburg MJ, Shaw D, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3:e360–e370. doi:10.1016/S2589-7500(21)00077-7
   PubMedGoogle Scholar
• Manoharan A, Manchanda V, Balasubramanian S, et al. Invasive pneumococcal disease in children aged younger than 5 years in India: a surveillance study. Lancet Infect Dis. 2017;17:305–312. doi:10.1016/S1473-3099(16)30466-2
   PubMed Web of Science ®Google Scholar
• Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: opportunities for prevention in the conjugate vaccine era. JAMA. 2001;285:1729–1735. doi:10.1001/jama.285.13.1729
   PubMed Web of Science ®Google Scholar
• Berezin EN, Jarovsky D, Cardoso MRA, et al. Invasive pneumococcal disease among hospitalized children in Brazil before and after the introduction of a pneumococcal conjugate vaccine. Vaccine. 2020;3:1740–1745. doi:10.1016/j.vaccine.2019.12.038
   Google Scholar
• Perniciaro S, Imöhl M, Linden M. Invasive pneumococcal disease in refugee children, Germany. Emerg Infect Dis. 2018;24:1934–1936. doi:10.3201/eid2410.180253
   PubMed Web of Science ®Google Scholar
• Yildirim I, Shea KM, Little BA, et al. Members of the Massachusetts Department of Public Health. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease. Pediatrics. 2015;135:495–503. doi:10.1542/peds.2014-2426
   PubMed Web of Science ®Google Scholar
• Desmet S, Lagrou K, Thomas CW, et al. Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study. Lancet Infect Dis. 2021;21:127–136. doi:10.1016/S1473-3099(20)30173-0
   PubMed Web of Science ®Google Scholar
• Jaiswal N, Singh M, Das RR, et al. Distribution of serotypes, vaccine coverage, and antimicrobial susceptibility pattern of Streptococcus pneumoniae in children living in SAARC countries: a systematic review. PLoS One. 2014;9:e108617. doi:10.1371/journal.pone.0108617
   PubMed Web of Science ®Google Scholar
• Muñoz-Almagro C, Ciruela P, Esteva C, et al. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in catalonia. Spain J Infect. 2011;63:151–162. doi:10.1016/j.jinf.2011.06.002
   PubMed Web of Science ®Google Scholar
• Chen TM, Li WH, Wang F, et al. Antibiotics prescription for targeted therapy of pediatric invasive pneumococcal diseases in China: a multicenter retrospective study. BMC Infect Dis. 2021;21:1156. doi:10.1186/s12879-021-06860-8
   PubMed Web of Science ®Google Scholar
• Nakano S, Fujisawa T, Ito Y, et al. Streptococcus pneumoniae pneumococcal disease after serotype 12F-CC4846 and invasive introduction of 13-valent pneumococcal conjugate. Emerg Infect Dis. 2020;26:2660–2668. doi:10.3201/eid2611.200087
   PubMed Web of Science ®Google Scholar
• Nakano S, Fujisawa T, Ito Y, et al. Spread of meropenem-resistant Streptococcus pneumoniae serotype 15A-ST63 clone in Japan, 2012–2014. Emerg Infect Dis. 2018;24:275–283. doi:10.3201/eid2402.171268
   PubMed Web of Science ®Google Scholar